vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and National Vision Holdings, Inc. (EYE). Click either name above to swap in a different company.
National Vision Holdings, Inc. is the larger business by last-quarter revenue ($487.3M vs $359.9M, roughly 1.4× AdvanSix Inc.). National Vision Holdings, Inc. runs the higher net margin — 0.7% vs -0.8%, a 1.5% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 7.9%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $30.3M). Over the past eight quarters, National Vision Holdings, Inc.'s revenue compounded faster (7.6% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Vision Research is an international company that manufactures high-speed digital cameras based in Wayne, New Jersey. Their cameras are marketed under the Phantom brand, and are used in a broad variety of industries including: defense, industrial product development, manufacturing, automotive, scientific research, and entertainment. Vision Research is a business unit of the Materials Analysis Division of Ametek Inc., a global manufacturer of electronic instruments and electromechanical devices.
ASIX vs EYE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $487.3M |
| Net Profit | $-2.8M | $3.4M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 2.0% |
| Net Margin | -0.8% | 0.7% |
| Revenue YoY | 9.4% | 7.9% |
| Net Profit YoY | -892.9% | 139.8% |
| EPS (diluted) | $-0.11 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | — | ||
| Q3 25 | $374.5M | $487.3M | ||
| Q2 25 | $410.0M | $486.4M | ||
| Q1 25 | $377.8M | $510.3M | ||
| Q4 24 | $329.1M | $437.3M | ||
| Q3 24 | $398.2M | $451.5M | ||
| Q2 24 | $453.5M | $451.7M | ||
| Q1 24 | $336.8M | $482.8M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.6M | $3.4M | ||
| Q2 25 | $31.4M | $8.7M | ||
| Q1 25 | $23.3M | $14.2M | ||
| Q4 24 | $352.0K | $-28.6M | ||
| Q3 24 | $22.3M | $-8.5M | ||
| Q2 24 | $38.9M | $-3.1M | ||
| Q1 24 | $-17.4M | $11.7M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.9% | 2.0% | ||
| Q2 25 | 7.7% | 3.4% | ||
| Q1 25 | 7.7% | 5.1% | ||
| Q4 24 | -3.9% | -5.8% | ||
| Q3 24 | 7.5% | -2.0% | ||
| Q2 24 | 11.5% | 0.1% | ||
| Q1 24 | -7.0% | 4.9% |
| Q4 25 | -0.8% | — | ||
| Q3 25 | -0.7% | 0.7% | ||
| Q2 25 | 7.7% | 1.8% | ||
| Q1 25 | 6.2% | 2.8% | ||
| Q4 24 | 0.1% | -6.5% | ||
| Q3 24 | 5.6% | -1.9% | ||
| Q2 24 | 8.6% | -0.7% | ||
| Q1 24 | -5.2% | 2.4% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | $0.04 | ||
| Q2 25 | $1.15 | $0.11 | ||
| Q1 25 | $0.86 | $0.18 | ||
| Q4 24 | $0.02 | $-0.36 | ||
| Q3 24 | $0.82 | $-0.11 | ||
| Q2 24 | $1.43 | $-0.04 | ||
| Q1 24 | $-0.65 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $56.0M |
| Total DebtLower is stronger | — | $236.5M |
| Stockholders' EquityBook value | $815.2M | $858.8M |
| Total Assets | $1.7B | $2.0B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | $56.0M | ||
| Q2 25 | $18.4M | $48.5M | ||
| Q1 25 | $8.3M | $80.0M | ||
| Q4 24 | $19.6M | $73.9M | ||
| Q3 24 | $17.3M | $81.2M | ||
| Q2 24 | $12.1M | $179.5M | ||
| Q1 24 | $20.6M | $150.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $236.5M | ||
| Q2 25 | — | $255.6M | ||
| Q1 25 | — | $244.7M | ||
| Q4 24 | — | $248.6M | ||
| Q3 24 | — | $252.8M | ||
| Q2 24 | — | $143.9M | ||
| Q1 24 | — | $448.6M |
| Q4 25 | $815.2M | — | ||
| Q3 25 | $818.2M | $858.8M | ||
| Q2 25 | $823.7M | $850.6M | ||
| Q1 25 | $794.4M | $836.2M | ||
| Q4 24 | $774.6M | $816.3M | ||
| Q3 24 | $766.4M | $840.0M | ||
| Q2 24 | $746.6M | $843.4M | ||
| Q1 24 | $713.2M | $841.3M |
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | $2.0B | ||
| Q2 25 | $1.6B | $2.0B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.6B | $2.0B | ||
| Q3 24 | $1.5B | $2.0B | ||
| Q2 24 | $1.5B | $2.1B | ||
| Q1 24 | $1.5B | $2.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.28× | ||
| Q2 25 | — | 0.30× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $46.6M |
| Free Cash FlowOCF − Capex | $36.1M | $30.3M |
| FCF MarginFCF / Revenue | 10.0% | 6.2% |
| Capex IntensityCapex / Revenue | 7.7% | 3.4% |
| Cash ConversionOCF / Net Profit | — | 13.83× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $83.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | — | ||
| Q3 25 | $26.6M | $46.6M | ||
| Q2 25 | $21.1M | $54.3M | ||
| Q1 25 | $11.4M | $32.2M | ||
| Q4 24 | $64.2M | $30.3M | ||
| Q3 24 | $57.3M | $27.9M | ||
| Q2 24 | $50.2M | $51.5M | ||
| Q1 24 | $-36.2M | $24.0M |
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | $30.3M | ||
| Q2 25 | $-7.2M | $42.4M | ||
| Q1 25 | $-22.6M | $12.0M | ||
| Q4 24 | $29.8M | $-1.7M | ||
| Q3 24 | $26.8M | $4.1M | ||
| Q2 24 | $16.7M | $31.9M | ||
| Q1 24 | $-71.6M | $4.0M |
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | 6.2% | ||
| Q2 25 | -1.7% | 8.7% | ||
| Q1 25 | -6.0% | 2.4% | ||
| Q4 24 | 9.1% | -0.4% | ||
| Q3 24 | 6.7% | 0.9% | ||
| Q2 24 | 3.7% | 7.1% | ||
| Q1 24 | -21.3% | 0.8% |
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | 3.4% | ||
| Q2 25 | 6.9% | 2.4% | ||
| Q1 25 | 9.0% | 4.0% | ||
| Q4 24 | 10.4% | 7.3% | ||
| Q3 24 | 7.7% | 5.3% | ||
| Q2 24 | 7.4% | 4.3% | ||
| Q1 24 | 10.5% | 4.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 13.83× | ||
| Q2 25 | 0.67× | 6.22× | ||
| Q1 25 | 0.49× | 2.27× | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | 2.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
EYE
Segment breakdown not available.
